Search by Drug Name or NDC

    NDC 70000-0523-01 Leader Maximum Strength Urinary Pain Relief 99.5 mg/1 Details

    Leader Maximum Strength Urinary Pain Relief 99.5 mg/1

    Leader Maximum Strength Urinary Pain Relief is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Cardinal Health. The primary component is PHENAZOPYRIDINE HYDROCHLORIDE.

    Product Information

    NDC 70000-0523
    Product ID 70000-0523_92cfa4d4-64ba-44ab-93ea-99d2bf229586
    Associated GPIs 56300010100353
    GCN Sequence Number 079502
    GCN Sequence Number Description phenazopyridine HCl TABLET 99.5 MG ORAL
    HIC3 R5A
    HIC3 Description URINARY TRACT ANESTHETIC/ANALGESIC AGNT (AZO-DYE)
    GCN 46004
    HICL Sequence Number 004108
    HICL Sequence Number Description PHENAZOPYRIDINE HCL
    Brand/Generic Generic
    Proprietary Name Leader Maximum Strength Urinary Pain Relief
    Proprietary Name Suffix n/a
    Non-Proprietary Name PHENAZOPYRIDINE HYDROCHLORIDE
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 99.5
    Active Ingredient Units mg/1
    Substance Name PHENAZOPYRIDINE HYDROCHLORIDE
    Labeler Name Cardinal Health
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category UNAPPROVED DRUG OTHER
    Application Number n/a
    Listing Certified Through 2024-12-31

    Package

    NDC 70000-0523-01 (70000052301)

    NDC Package Code 70000-0523-1
    Billing NDC 70000052301
    Package 1 BLISTER PACK in 1 CARTON (70000-0523-1) / 12 TABLET in 1 BLISTER PACK
    Marketing Start Date 2019-10-10
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.18625
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description URINARY PAIN RELIEF 99.5 MG TB
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis